Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
6.68(c) 6.87(c) 7.14(c) 7.38(c) 7.38(c) Last
474 932 517 912 591 603 509 903 968 952 Volume
+2.77% +2.84% +3.93% +3.36% 0.00% Change
More quotes
Financials ($)
Sales 2017 120 M
EBIT 2017 -77,0 M
Net income 2017 -84,9 M
Debt 2017 -
Yield 2017 -
Sales 2018 126 M
EBIT 2018 -54,0 M
Net income 2018 -60,6 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 4,95x
Capi. / Sales2018 4,72x
Capitalization 593 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products.It targets non-Hodgkin's lymphoma, advanced metastatic colorectal cancer, acute lymphoblastic leukemia, and multiple myeloma.It operates through... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
06/19 SPECTRUM PHARMACEUTICALS : Highlights Results of a Combination Study of FOLOTYN®..
06/16 SPECTRUM PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holde..
06/09 SPECTRUM PHARMACEUTICALS : Highlights Three Abstracts of Clinical Data at the 20..
06/09 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Jefferies 2017 Glo..
06/05 SPECTRUM PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (..
06/02 SPECTRUM PHARMACEUTICALS : Highlights Three Abstracts of Clinical Data at the 20..
05/30 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Jefferies 2017 Glo..
05/16 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Bank of America Me..
05/02 SPECTRUM PHARMACEUTICALS, INC. (NASD : SPPI) Files An 8-K Results of Operations ..
05/02 SPECTRUM PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
More news
Sector news : Biotechnology & Medical Research - NEC
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
06/20KBC Group NV Has $554,000 Stake in Spectrum Pharmaceuticals, Inc. $SPPI  
06/19Spectrum Pharma's Folotyn and Celgene's Istodax combo shows treatment effect .. 
06/19Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN.. 
06/19-$0.04 Earnings Per Share Expected for CASI Pharmaceuticals, Inc. $CASI This .. 
06/14Spectrum Pharmaceuticals, Inc. $SPPI Given a $9.00 Price Target by Jefferies .. 
More tweets
Qtime:22
News from SeekingAlpha
06/19 Spectrum Pharma's Folotyn and Celgene's Istodax combo shows treatment effect ..
05/22 Spectrum Pharmaceuticals (SPPI) Bank of America Merrill Lynch 2017 Health Car..
05/03 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
05/02 Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q1 2017 Results - Ea..
05/02 Spectrum Pharmaceuticals -7% off Q1 earnings miss
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 10,0 $
Spread / Average Target 36%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Rajesh C. Shrotriya Chairman & Chief Executive Officer
Joseph W. Turgeon President & Chief Operating Officer
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
Stuart Mitchell Krassner Independent Non-Employee Director
Luigi Lenaz Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SPECTRUM PHARMACEUTICA..66.59%593
INCYTE CORPORATION35.91%27 774
QUINTILES IMS HOLDINGS..19.50%19 614
LONZA GROUP27.12%15 927
CELLTRION, INC.--.--%12 175
SEATTLE GENETICS, INC.19.86%9 027
More Results